Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Spero Therapeutics, Inc. (SPRO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 0% stake in Spero Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 0% stake in SPERO THERAPEUTICS, INC. |
| 10/03/2022 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 9.8% stake in SPERO THERAPEUTICS, INC. |
| 03/08/2022 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 15.5% stake in SPERO THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 15.4% stake in SPERO THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in Spero Therapeutics, Inc. |
| 02/03/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/25/2022 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 4.3% stake in spero therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 14.5% stake in SPERO THERAPEUTICS, INC. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/22/2020 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 17.4% stake in SPERO THERAPEUTICS, INC. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 6% stake in SPERO THERAPEUTICS, INC. |
| 02/04/2020 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 7.2% stake in SPERO THERAPEUTICS, Inc. |
| 01/31/2020 |
SC 13G/A
| Lundbeckfond Invest A/S reports a 4.6% stake in Spero Therapeutics, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 6% stake in SPERO THERAPEUTICS, INC. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|